Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tianjin Botanic Century is a biotechnology company specializing in the discovery and development of bioactive compounds derived from natural plant sources. The company leverages a proprietary high-throughput screening platform and an extensive library of plant extracts to identify novel candidates for metabolic and chronic diseases. Their primary focus lies in developing natural alternatives and adjunct therapies for conditions such as type 2 diabetes, obesity, and hyperlipidemia. Botanic Century provides both proprietary health products and specialized research services, including the supply of high-purity reference standards and customized extraction solutions. By bridging traditional herbal knowledge with modern pharmacological screening, the company aims to deliver scientifically validated natural health solutions to the global market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tianjin Botanic Century.